Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Vivimedi Oy
OY
Active
Y-tunnus 2046176-0
Vanattarantie 2, 37550
Lempäälä
Wholesale of pharmaceutical and medical goods
· NACE 4646
Est. 2006
— employees
www.vivimedi.fi
Watchlist
Share
Finland
/
Companies
/
Wholesale of pharmaceutical and medical goods
/
Vivimedi Oy
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
EUR millions
0M
1M
2M
3M
3M
3M
2020
2M
2021
2M
2022
3M
2023
1M
2024
EBITDA
EUR millions
0M
0M
1M
1M
1M
1M
2020
0M
2021
0M
2022
1M
2023
0M
2024
Income statement
EUR thousands
Item
2020
2021
2022
2023
2024
Revenue
2 920
1 995
1 932
2 990
629
Staff expenses
−281
−311
−297
−213
−183
EBITDA
918
307
−23
1 121
−56
Depreciation & amort.
−6
−5
−4
−44
−36
EBIT
912
302
−27
1 077
−93
Net financials
7
194
−0
111
176
Profit before tax
919
496
−27
1 188
83
Tax
188
95
−0
232
17
Net profit
731
400
−27
956
66
Balance sheet
EUR thousands
Item
2020
2021
2022
2023
2024
Total assets
4 745
4 787
5 421
5 021
5 180
Equity
4 064
4 139
3 781
4 737
4 803
Long-term debt
—
—
0
0
0
Short-term debt
681
648
1 640
285
377
Total debt
681
648
1 640
285
377
Financial ratios
5-year trend
EBITDA margin
-9.0%
This company
15.8%
Market median
-157% vs market
2020
2024
Equity ratio
92.7%
This company
38.2%
Market median
+143% vs market
2020
2024
Return on equity
1.4%
This company
18.4%
Market median
-92% vs market
2020
2024
Net profit margin
10.5%
This company
8.1%
Market median
+30% vs market
2020
2024
Asset turnover
0.12×
This company
1.12×
Market median
-89% vs market
2020
2024
Debt / equity
0.08×
This company
0.62×
Market median
+87% vs market
2020
2024
Annual reports & filings
Annual report 2024
Filed via PRH / YTJ · Period 2023-10-01 – 2024-09-30
View
PDF
Annual report 2023
Filed via PRH / YTJ · Period 2022-10-01 – 2023-09-30
View
PDF
Annual report 2022
Filed via PRH / YTJ · Period 2021-10-01 – 2022-09-30
View
PDF
Annual report 2021
Filed via PRH / YTJ · Period 2020-10-01 – 2021-09-30
View
PDF
Annual report 2020
Filed via PRH / YTJ · Period 2019-10-01 – 2020-09-30
View
PDF
More on Vivimedi Oy
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network